St. Luke's Honored with 2 Mission: Lifeline Awards - 2019 Mission: Lifeline STEMI Gold Plus Receiving & NSTEMI Gold Awards
St. Luke’s is proud to announce it has earned the American Heart Association’s (AHA) 2019 Mission: Lifeline® STEMI Gold Plus Receiving Award and NSTEMI Gold Award.
St. Luke’s earned the awards for its commitment and success in implementing specific quality improvement measures outlined by the AHA for the treatment of patients who suffer severe heart attacks.
“It is an unfortunate reality that people experience heart attack every day,” Dr. Scott Mikesell, director of St. Luke’s Cardiac Cath Labs and co-chair of Mission: Lifeline Minnesota said. “Our singular focus is to deliver the highest standard of care so our patients can go back home to their loved ones and enjoy living a better quality of life. Following the guidelines set by Mission: Lifeline allows us to strive for excellence and make that happen.”
Each year in the United States, more than 250,000 people have a STEMI, or ST-segment Elevation Myocardial Infarction. It is the deadliest type of heart attack and is caused by a complete blockage of blood flow to the heart. To prevent death, it’s critical to immediately restore blood flow, either by surgically opening the blocked vessel or by giving clot-busting medication. The AHA’s Mission: Lifeline program’s goal is to reduce system barriers to prompt treatment for heart attacks, beginning with the 9-1-1 call and continuing through hospital treatment.
To further enhance cardiac care, St. Luke’s is creating a new space for its Cardiac Cath Labs as part of its campus expansion project. The new Cath Labs will offer cutting-edge technology for patients and world-class imaging capabilities. There’s also going to be a recovery area, allowing the team to continue caring for patients within the space immediately following a procedure. More importantly though, it will be right next to St. Luke’s new Emergency Department and helistop. That will mean saving precious time and treating patients faster than ever before. The new Cath Labs are scheduled to open in July of 2020.